ACM
AlphaCrest Capital Management’s Eli Lilly LLY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,434
| Closed | -$464K | – | 642 |
|
|
2022
Q3 | $464K | Sell |
1,434
-6,799
| -83% | -$2.2M | 0.03% | 1010 |
|
|
2022
Q2 | $2.67M | Buy |
8,233
+2,051
| +33% | +$665K | 0.13% | 196 |
|
|
2022
Q1 | $1.77M | Sell |
6,182
-2,708
| -30% | -$775K | 0.1% | 286 |
|
|
2021
Q4 | $2.46M | Sell |
8,890
-16,650
| -65% | -$4.6M | 0.09% | 325 |
|
|
2021
Q3 | $5.9M | Buy |
25,540
+9,786
| +62% | +$2.26M | 0.31% | 34 |
|
|
2021
Q2 | $3.62M | Sell |
15,754
-42,764
| -73% | -$9.82M | 0.16% | 177 |
|
|
2021
Q1 | $10.9M | Buy |
58,518
+48,061
| +460% | +$8.98M | 0.61% | 12 |
|
|
2020
Q4 | $1.77M | Sell |
10,457
-12,544
| -55% | -$2.12M | 0.15% | 168 |
|
|
2020
Q3 | $3.41M | Buy |
23,001
+12,836
| +126% | +$1.9M | 0.37% | 26 |
|
|
2020
Q2 | $1.67M | Sell |
10,165
-16,380
| -62% | -$2.69M | 0.28% | 60 |
|
|
2020
Q1 | $3.68M | Buy |
26,545
+24,345
| +1,107% | +$3.38M | 0.45% | 8 |
|
|
2019
Q4 | $289K | Sell |
2,200
-13,475
| -86% | -$1.77M | 0.02% | 1083 |
|
|
2019
Q3 | $1.75M | Sell |
15,675
-55,353
| -78% | -$6.19M | 0.11% | 295 |
|
|
2019
Q2 | $7.87M | Buy |
71,028
+68,609
| +2,836% | +$7.6M | 0.68% | 2 |
|
|
2019
Q1 | $314K | Sell |
2,419
-1,781
| -42% | -$231K | 0.05% | 642 |
|
|
2018
Q4 | $486K | Buy |
+4,200
| New | +$486K | 0.14% | 254 |
|